| Financial Year |
March 31 2023 |
| Monetary Funds |
29,201,844.38 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,060,588,376.40 |
| Advances to Suppliers |
94,909,704.90 |
| Other Receivables |
54,634,009.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
15,395,035.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
40,271,928.10 |
| Total Current Assets |
1,440,327,120.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,064,490.78 |
| Investment Properties |
-- |
| Fixed Assetes |
2,430,264.68 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,145.70 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
79,527,072.72 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
94,772,660.95 |
| Total Assets |
1,535,099,781.92 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,478,887,037.30 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,702,877.44 |
| Taxes Payable |
8,689,875.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
204,938,377.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
749,940.15 |
| Other Current Liabilities |
112,237,789.11 |
| Sub-Total of Current Liabilities |
1,856,239,848.32 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
204,055.00 |
| Total Liabilities |
1,856,443,903.32 |
| Paid-In Capital(Or Share Stock) |
75,990,382.66 |
| Capital Surplus |
186,177,230.57 |
| Surplus Reserve |
30,223,743.53 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-616,648,754.30 |
| Minority Stockholder's Interest |
2,913,276.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-324,257,397.54 |
| Owner's Equity（Stockholder's Equity） |
-321,344,121.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,535,099,781.92 |
